203 related articles for article (PubMed ID: 17503093)
1. Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat.
Yasui H; Adachi Y; Katoh A; Sakurai H
J Biol Inorg Chem; 2007 Aug; 12(6):843-53. PubMed ID: 17503093
[TBL] [Abstract][Full Text] [Related]
2. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
3. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406
[TBL] [Abstract][Full Text] [Related]
4. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
Sakurai H; Sano H; Takino T; Yasui H
J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469
[TBL] [Abstract][Full Text] [Related]
5. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
6. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid.
Nakai M; Obata M; Sekiguchi F; Kato M; Shiro M; Ichimura A; Kinoshita I; Mikuriya M; Inohara T; Kawabe K; Sakurai H; Orvig C; Yano S
J Inorg Biochem; 2004 Jan; 98(1):105-12. PubMed ID: 14659639
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy.
Fugono J; Yasui H; Sakurai H
J Pharm Pharmacol; 2001 Sep; 53(9):1247-55. PubMed ID: 11578107
[TBL] [Abstract][Full Text] [Related]
9. Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor.
Hiromura M; Nakayama A; Adachi Y; Doi M; Sakurai H
J Biol Inorg Chem; 2007 Nov; 12(8):1275-87. PubMed ID: 17805585
[TBL] [Abstract][Full Text] [Related]
10. Metallokinetic analysis of disposition of vanadyl complexes as insulin-mimetics in rats using BCM-ESR method.
Yasui H; Takechi K; Sakurai H
J Inorg Biochem; 2000 Feb; 78(3):185-96. PubMed ID: 10805174
[TBL] [Abstract][Full Text] [Related]
11. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
12. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Dabroś W; Kajda B
Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
[TBL] [Abstract][Full Text] [Related]
13. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
Adachi Y; Sakurai H
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957
[TBL] [Abstract][Full Text] [Related]
14. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
Woo LC; Yuen VG; Thompson KH; McNeill JH; Orvig C
J Inorg Biochem; 1999 Sep; 76(3-4):251-7. PubMed ID: 10605840
[TBL] [Abstract][Full Text] [Related]
15. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
16. Study of the antidiabetic capacity of the VO(dmpp)2 complex.
Passadouro M; Metelo AM; Melão AS; Pedro JR; Faneca H; Carvalho E; Castro MM
J Inorg Biochem; 2010 Sep; 104(9):987-92. PubMed ID: 20627316
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids.
Kawabe K; Sasagawa T; Yoshikawa Y; Ichimura A; Kumekawa K; Yanagihara N; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2003 Nov; 8(8):893-906. PubMed ID: 14551811
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode.
Rangel M; Tamura A; Fukushima C; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):128-32. PubMed ID: 11293405
[TBL] [Abstract][Full Text] [Related]
19. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
20. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]